Zhonghua Kou Qiang Yi Xue Za Zhi
Email:
Published: September 2014
Objective: To study the incorporation rate and release behavior of bovine serum albumin (BSA) incorporated into the calcium phosphate coating by biomimetic deposition, as well as the physical and chemical properties of the hybrid coating, and to provide experimental basis for the fabrication of growth factor/biomimetic calcium phosphate coating and exploration for the loading/release behavior of growth factors.
Methods: Pure titanium specimens were immersed into saturated calcium phosphate solutions(SCP) containing no BSA (controlled group) and 3 different concentrations of BSA (experimental groups) : 1, 10 and 100 mg/L. Biomimetic calcium phosphate coating was formed on titanium surface and BSA was incorporated into the coating through co-deposition. The topography of the specimen was observed using scanning electron microscopy (SEM). Chemical structure and phase composition of coatings were detected by Fourier infrared spectroscopy (FTIR) analysis and X-ray diffraction (XRD) respectively. BSA incorporation rate and release profile were determined by bicinchoninic acid protein assay kit.
Results: The biomimetic calcium phosphate coating was mainly composed of hydroxyapatite and octacalcium phosphate. BSA was successfully incorporated into the calcium phosphate coatings in all the 3 experimental groups. With the increase of BSA concentration, plate-like units of the coatings were turned into small grid structure. BSA incorporation rates of the three experimental groups were (72.4 ± 2.4)%, (62.3 ± 0.9)% and (42.2 ± 1.7)% respectively. The in vitro release test showed that all three BSA release profiles could be divided into two significant different stages: early burst release stage and later sustained release stage. The amount of BSA release of the 3 experimental groups in 24 h and 30 d were (1.57 ± 0.09), (8.82 ± 0.93), (140.24 ± 3.12) µg, and (2.39 ± 0.29), (14.39 ± 0.70), (151.06 ± 2.00) µg respectively.
Conclusions: Biomimetic calcium phosphate coating can be used as an effective carrier for protein. BSA concentration has an impact on the incorporation rate and release speed of BSA from the calcium phosphate coating. Favorable BSA incorporation rate and release behavior can be obtained at BSA concentration of 10 mg/L.
Download full-text PDF |
Source |
---|
Clin J Am Soc Nephrol
March 2025
Division of Nephrology, Endocrinology, and Metabolism, Tokai University School of Medicine, Kanagawa, Japan.
Background: It is necessary to update the evidence of each phosphate-lowering agent on dialysis patients.
Methods: From the CENTRAL, MEDLINE, EMBASE, and ClinicalTrial.gov databases, randomized controlled trials (RCTs) using oral phosphate-lowering agents on adult patients requiring maintenance dialysis were extracted.
Int Urol Nephrol
March 2025
Mayo Clinic, 200 First St SW, Rochester, MN, 55902, USA.
Objectives: To provide updated population-level data on stone composition by characterizing changes in the prevalence of kidney stone composition by patient age, gender, and geographic location using data from a large tertiary stone analysis laboratory.
Methods: The [redacted for anonymity] receives kidney stone specimens for analysis by infrared spectroscopy. All stones submitted over a 12-month period (December 2022-November 2023) are included in this report.
Comput Methods Biomech Biomed Engin
March 2025
School of Mechanical Engineering and Automation, Northeastern University, Shenyang, China.
By establishing micro finite element models of cement-bone composite materials and fusion surgery models (C4-C7), the mechanical properties of cement-bone composite materials (Polymethyl methacrylate (PMMA) and a mixture of PMMA and calcium phosphate bone cement (PMMA/CPC)) were analyzed, and the influence of bone cement on the biomechanical properties of anterior cervical discectomy fusion surgery with partial vertebral osteotomy was evaluated. The results revealed that compared with bone cement, the elastic modulus of cement-bone composite material decreased, the PMMA/CPC+bone (osteoporosis) decreased by 73.65% compared to PMMA/CPC.
View Article and Find Full Text PDFFront Pharmacol
February 2025
Department of Orthopaedics, Second Affiliated Hospital, Air Force Medical University, Xi'an, China.
Bone infection remains a challenging condition to fully eradicate due to its intricate nature. Traditional treatment strategies, involving long-term and high-dose systemic antibiotic administration, often encounter difficulties in achieving therapeutic drug concentrations locally and may lead to antibiotic resistance. Bone cement, serving as a local drug delivery matrix, has emerged as an effective anti-infective approach validated in clinical settings.
View Article and Find Full Text PDFMaterials (Basel)
March 2025
Graduate Program in Applied Dental Sciences, Bauru School of Dentistry, University of Sao Paulo, Bauru 17012-901, Brazil.
Repairing hard tissues, such as bones, remains a significant challenge, especially in adverse clinical conditions. Calcium hydroxyapatite (CaHA), a calcium phosphate (CaP), has structural and chemical characteristics similar to the mineral structure of human bones and teeth, offering bioactivity and biocompatibility properties. Photobiomodulation (PBM) uses light to reduce inflammation and accelerate tissue healing.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.